BAMF
BI Asset Management Fondsmaeglerselskab Portfolio holdings
AUM
$10.2B
This Quarter Return
+12.86%
1 Year Return
+26.9%
3 Year Return
+101.23%
5 Year Return
+181.82%
10 Year Return
+407.9%
AUM
$2.3B
AUM Growth
+$2.3B
(+4.3%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-5.43%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
510
New
53
Increased
114
Reduced
178
Closed
133
Top Buys
| 1 |
Kimberly-Clark
KMB
|
$31.5M |
| 2 |
AstraZeneca
AZN
|
$25.4M |
| 3 |
TFI International
TFII
|
$21.7M |
| 4 |
CVS Health
CVS
|
$21.6M |
| 5 |
Comcast
CMCSA
|
$13.5M |
Top Sells
| 1 |
Paychex
PAYX
|
$34.7M |
| 2 |
Pfizer
PFE
|
$26.7M |
| 3 |
Magna International
MGA
|
$10.6M |
| 4 |
Adobe
ADBE
|
$10.3M |
| 5 |
Sysco
SYY
|
$9.53M |
Sector Composition
| 1 | Technology | 23.04% |
| 2 | Healthcare | 16.42% |
| 3 | Consumer Discretionary | 12.7% |
| 4 | Financials | 12.48% |
| 5 | Consumer Staples | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
DTE Energy
DTE
$28.4B
| $26.2M | 1.14% |
215,787
-27,387
| -11% | -$3.32M |
|
27
Public Service Enterprise Group
PEG
$41.1B
| $25.8M | 1.13% |
443,382
-35,877
| -7% | -$2.09M |
|
28
Travelers Companies
TRV
$61.1B
| $25.5M | 1.11% |
181,691
-25,892
| -12% | -$3.63M |
|
|
29
AstraZeneca
AZN
$248B
| $25.4M | 1.1% |
+507,167
| New | +$25.4M |
|
30
Avery Dennison
AVY
$13.4B
| $25M | 1.09% |
161,469
-59,192
| -27% | -$9.18M |
|
31
Abbott
ABT
$231B
| $24.9M | 1.08% |
227,403
-31,848
| -12% | -$3.49M |
|
32
Tractor Supply
TSCO
$32.7B
| $24.8M | 1.08% |
176,149
-3,728
| -2% | -$524K |
|
|
33
CVS Health
CVS
$92.8B
| $24.5M | 1.07% |
359,023
+315,879
| +732% | +$21.6M |
|
34
Mastercard
MA
$538B
| $21.9M | 0.95% |
61,314
+19,535
| +47% | +$6.97M |
|
|
35
TFI International
TFII
$7.87B
| $21.7M | 0.94% |
+420,944
| New | +$21.7M |
|
36
Visa
V
$683B
| $20.5M | 0.89% |
93,828
-13,266
| -12% | -$2.9M |
|
37
JPMorgan Chase
JPM
$829B
| $19.7M | 0.86% |
154,991
+25,903
| +20% | +$3.29M |
|
38
NVIDIA
NVDA
$4.24T
| $18.4M | 0.8% |
35,282
+4,449
| +14% | +$2.32M |
|
39
Salesforce
CRM
$245B
| $18.3M | 0.8% |
82,249
+49,322
| +150% | +$11M |
|
40
Morgan Stanley
MS
$240B
| $16M | 0.7% |
233,337
+111,891
| +92% | +$7.67M |
|
41
Amgen
AMGN
$155B
| $15.4M | 0.67% |
66,973
+18,078
| +37% | +$4.16M |
|
42
Intel
INTC
$107B
| $15.1M | 0.66% |
302,711
-90,052
| -23% | -$4.49M |
|
43
Bristol-Myers Squibb
BMY
$96B
| $15M | 0.65% |
241,337
+61,620
| +34% | +$3.82M |
|
44
Cognizant
CTSH
$35.3B
| $13.9M | 0.6% |
169,150
+76,213
| +82% | +$6.25M |
|
|
MXIM
45
DELISTED
Maxim Integrated Products
MXIM
| $13.8M | 0.6% |
155,955
+134,784
| +637% | +$11.9M |
|
46
Tyson Foods
TSN
$20.2B
| $13.2M | 0.58% |
205,571
+153,358
| +294% | +$9.88M |
|
47
NetEase
NTES
$86.2B
| $13.1M | 0.57% |
136,908
+120,964
| +759% | +$11.6M |
|
48
Charles Schwab
SCHW
$174B
| $12.9M | 0.56% |
243,891
+225,019
| +1,192% | +$11.9M |
|
49
Vertex Pharmaceuticals
VRTX
$100B
| $12.8M | 0.56% |
54,267
+30,501
| +128% | +$7.21M |
|
50
AbbVie
ABBV
$372B
| $12.8M | 0.56% |
119,659
-55,197
| -32% | -$5.91M |
|